Br J Ophthalmol 1999;83:501 ( April )
Letters to the editor
Diagnosis of corticosteroid resistant ocular sarcoidosis by
chorioretinal biopsy
EDITOR,
Sarcoidosis, a multisystem granulomatous
disease, involves the eye in approximately 25% to 50% of
patients1 2 and produces numerous ocular
findings.3 Definitive diagnosis requires a non-caseating
granuloma in the absence of mycobacterial infection on biopsy. Although
most patients have abnormal chest x rays,
ocular sarcoidosis can precede pulmonary involvement, making diagnosis
difficult. The following patient with ocular sarcoidosis
unresponsive
to corticosteroids and cyclosporine
was diagnosed only after
chorioretinal biopsy; she responded to azathioprine therapy.
CASE REPORT
A 32 year old white woman had a 12 year history of granulomatous
uveitis in both eyes, resistant to treatment with topical, periocular,
and systemic corticosteroids, as well as systemic cyclosporine. The
patient presented with intermediate uveitis of the left eye,
complicated by cystoid macular oedema, posterior subcapsular cataract,
and epiretinal membrane formation. In 1986, she underwent lensectomy,
vitrectomy, and membrane peeling with poor visual outcome. Laboratory
evaluation, including chest x ray and serum
angiotensin converting enzyme level, was normal.
In 1991, she developed active uveitis in the right eye with visual
acuity of 20/25; cystoid macular oedema developed, with scattered
lesions in the deep retina. The left eye decreased to hand movement.
Both eyes showed moderate anterior uveitis, vitritis, and chorioretinal
lesions (Fig 1), and a diagnosis of multifocal choroiditis was made.

View larger version (140K):
[in this window]
[in a new window]
|
Figure 1
Retinal photograph of the left eye shows substantial
vitreous haze. Scattered lesions at the levels of the deep retina and
choroid (arrows), as well as mottling of retinal pigment epithelium,
are seen in the posterior pole.
|
|
Chorioretinal lesions increased in size and number in both eyes,
despite cyclosporine, and vision in the right eye worsened to 20/60.
She developed peripheral retinal detachment, and a chorioretinal biopsy
was performed on the left eye.
Biopsy examination demonstrated a well defined, non-caseating choroidal
granuloma (Fig 2), predominantly macrophages surrounded by CD4+ T
lymphocytes and a few plasma cells. The retina was gliotic, infiltrated
with scattered lymphocytes and plasma cells. Higher expression of Fas,
FasL, and Bax, as well as lower expression of Bcl-2 and DNA
fragmentation were detected in the granuloma. No micro-organisms were
found. Cultures and stains for bacteria, mycobacteria, and fungi were
negative. These findings suggest that apoptosis occurs in choroidal
granuloma and plays a regulatory role in limiting ocular
inflammation.4

View larger version (136K):
[in this window]
[in a new window]
|
Figure 2
Photomicrograph of a chorioretinal biopsy from the
left eye shows a well defined, non-caseating choroidal granuloma
predominantly consisting of macrophages and a giant cell (arrow)
surrounded by lymphocytes and a few plasma cells. The retina is
gliotic, infiltrated with scattered lymphocytes and plasma cells. No
micro-organisms were found. (Haematoxylin and eosin; original
magnification ×200.)
|
|
Upon diagnosis of ocular sarcoidosis and treatment with azathioprine,
the patient's vision improved to 20/40 in her right eye and has
remained stable for 4 years.
COMMENT
This case illustrates several points: ocular sarcoidosis can occur in
the absence of pulmonary signs or symptoms and causes a plethora of
ocular findings; the disease eludes accurate diagnosis
in this case, a
chorioretinal biopsy excluded chronic infection and led to accurate
diagnosis5; and ocular sarcoidosis can resist corticosteroid therapy. This patient's disease progressed despite treatment with periocular and systemic corticosteroids and
cyclosporine, but responded to azathioprine. Azathioprine has been
used successfully to treat sight threatening ocular sarcoidosis at
1-1.25 mg/kg/day.6 Although sarcoidosis responds to
corticosteroids, other immunosuppressive agents may be needed to
control ocular disease.
SCOTT M WHITCUP, CHI-CHAO CHAN
National Eye Institute, National Institutes of Health, Bethesda,
MD, USA
GREER L GEIGER
Brockwood Eye Institute, Birmingham, AL, USA
Correspondence to: Scott M Whitcup, MD, National Institutes of
Health/National Eye Institute, 10/10S221 10 Center Dr MSC 1863, Bethesda, MD 20892-1863, USA.
Accepted for publication 5 November 1998
References
| 1.
|
Crick RP HC,
Smellie H. The eyes in sarcoidosis.
Br J Ophthalmol
1961;45:461-481[Free Full Text].
|
| 2.
|
Obenauf CD,
Shaw HE,
Sydnor CF,
et al. Sarcoidosis and its ophthalmic manifestations.
Am J Ophthalmol
1978;86:648-655[Medline].
|
| 3.
|
Jabs DA. Ocular involvement in chronic sarcoidosis.
Am J Ophthalmol
1986;102:297-301[Medline].
|
| 4.
|
Chan CC,
Qian L,
Whitcup SM,
et al. Apoptosis in patients with posterior uveitis.
Arch Ophthalmol
1997;115:1559-1567[Abstract].
|
| 5.
|
Martin DM,
Chann CC,
de Smet MD,
et al. The role of chorioretinal biopsy in the management of posterior uveitis.
Ophthalmology
1993;100:705-714[Medline].
|
| 6.
|
Krzystolik M,
Power WJ,
Foster CS. Diagnosis and therapeutic challenges of sarcoidosis.
Int Ophthal Clin
1998;38:61-76.
|
© 1999 by British Journal of Ophthalmology